Perimenopause in Finance: The Woman in PE, VC, and Hedge Funds
Women partners in private equity, venture capital, and hedge funds are navigating perimenopause inside one of the least forgiving professional cultures on earth — where vulnerability is weaponized and the disclosure calculus is genuinely complex. This post names the neurobiological reality, the specific ways perimenopause disrupts the cognitive tools finance demands, and what a real support structure looks like when the industry won’t build it for you.
- 7:10 a.m., the Investment Committee, and the Heat She Doesn’t Touch
- What Is Perimenopause and How Does It Affect Cognitive Function?
- The Neurobiology of Perimenopause and Risk Cognition
- How Perimenopause Shows Up in Driven Women in Finance
- The Disclosure Problem: Why Almost No One Talks
- Both/And: The Edge Is Still There and the Body Wants a Different Pace
- The Systemic Lens: A Male-Coded Industry at the Exact Moment Women’s Leadership Is Most Needed
- How to Heal: Building Your Own Support Structure
- Frequently Asked Questions
7:10 a.m., the Investment Committee, and the Heat She Doesn’t Touch
It’s 7:10 a.m. The fluorescent lights of the conference room cast a stark glow on the polished mahogany table. Vivian, 44-year-old PE partner, is mid-pitch to the Investment Committee. Her voice is steady. Her arguments are sharp. Every data point lands with precision.
But beneath the composed exterior, a different kind of heat is rising — sudden, intense, threatening to betray the carefully constructed composure. She doesn’t touch the water glass beside her. Her voice doesn’t shake. The deal closes.
By 9:30 a.m., alone in her car in the parking garage, the tears come — hot and fast, a release she can’t afford to show in the office. Not tears of sadness, exactly. Tears of something she doesn’t quite have a name for. The effort of it. The constant management. The years of having to function at maximum performance while managing an internal experience she can’t talk about with anyone in that building.
This is what perimenopause looks like in finance. Not dramatic collapse, but exquisitely private performance — and an accumulating cost that the industry doesn’t see, doesn’t measure, and doesn’t take seriously.
What Is Perimenopause and How Does It Affect Cognitive Function?
Perimenopause is the transitional phase preceding menopause — defined as twelve consecutive months without a menstrual period. What makes it particularly relevant for women in finance is that it isn’t primarily about physical symptoms, though those are real. It’s about the brain.
During perimenopause, estrogen and progesterone levels fluctuate erratically rather than declining smoothly. Those fluctuations affect the prefrontal cortex (decision-making, planning, inhibitory control), the hippocampus (memory formation and retrieval), and the neurotransmitter systems that govern emotional regulation and stress response. For women in PE, VC, and hedge funds — whose professional performance depends on rapid cognitive synthesis, risk calibration, and sustained focus under pressure — these neurological impacts aren’t abstract. They show up in the work.
Pauline M. Maki, PhD, Professor of Psychiatry, Psychology, and Obstetrics and Gynecology at the University of Illinois Chicago and a leading researcher in women’s cognitive health, defines perimenopause as a period in which fluctuating sex steroid hormones — particularly estrogen — can significantly affect cognitive abilities, mood, and stress responsivity. Her research documents measurable changes in verbal memory, processing speed, and attention that correspond with the hormonal volatility of the perimenopausal transition.
In plain terms: During perimenopause, the brain’s ability to think clearly, manage emotion, and handle stress can be genuinely affected by hormonal fluctuations — not because you’re losing your mind, but because the estrogen that quietly supported all of those functions is now unpredictable. In finance, where sharp cognition is the core product, that matters.
Rebecca C. Thurston, PhD, Pittsburgh Foundation Chair in Women’s Health and Dementia and Distinguished Professor of Psychiatry, Clinical and Translational Science, Epidemiology, and Psychology at the University of Pittsburgh, has documented a direct neurobiological link between vasomotor symptoms — hot flashes and night sweats — and neurocognitive function. Her research demonstrates that women who experience more severe or frequent vasomotor symptoms show measurable impairment in memory and executive function, independent of sleep disruption.
In plain terms: Hot flashes and night sweats aren’t just uncomfortable — they have a direct neurological impact on your ability to remember and focus, even separate from the sleep disruption they cause. If you’re having significant vasomotor symptoms, your cognitive performance is being affected in ways that go beyond just being tired.
The Neurobiology of Perimenopause and Risk Cognition
In finance, risk cognition is the core competency. The ability to synthesize incomplete information, tolerate uncertainty, make probabilistic judgments under time pressure, and maintain calibrated confidence rather than over- or under-weighting what you know — these are the cognitive skills that separate strong investors from average ones. And these are precisely the cognitive functions most sensitive to the neurobiological disruptions of perimenopause.
Estradiol — the primary and most potent form of estrogen — plays a direct role in prefrontal cortex function. When estradiol levels fluctuate unpredictably during perimenopause, the prefrontal cortex’s capacity for inhibitory control, working memory, and cognitive flexibility can be transiently reduced. Pauline M. Maki, PhD, Professor of Psychiatry, Psychology, and Obstetrics and Gynecology at the University of Illinois Chicago, has published extensively on how these estradiol fluctuations produce measurable changes in verbal memory and attention during the perimenopausal transition. Her work, published in journals including Menopause and Neurology, makes clear that this is a neurobiological event — not a psychological one.
Rebecca C. Thurston, PhD, Pittsburgh Foundation Chair in Women’s Health and Dementia at the University of Pittsburgh, adds a crucial layer. Her research demonstrates that vasomotor symptoms are associated with white matter hyperintensities — subtle structural changes in the brain — and with measurable cognitive difficulty independent of sleep disruption. In practical terms: the hot flash in your Investment Committee presentation isn’t just a physical discomfort. It’s a neurological event that is actively affecting brain performance in that moment.
Estradiol, the primary and most potent form of estrogen, plays a regulatory role in the hippocampus, prefrontal cortex, and the dopaminergic and serotonergic systems — all of which are central to memory, attention, executive planning, and emotional regulation. During perimenopause, significant fluctuations in estradiol directly impact these cognitive processes, producing the symptoms commonly described as brain fog, concentration difficulties, and altered judgment under pressure.
In plain terms: Estradiol is a key brain hormone, not just a reproductive one. When it fluctuates unpredictably during perimenopause, it affects the parts of your brain responsible for memory, focus, and how you assess and respond to risk. That’s not a personality change — it’s a neurobiological one, and it’s temporary.
There’s also the compounding effect of sleep disruption. Chronic sleep deprivation — which is nearly universal among women experiencing significant night sweats — impairs the prefrontal cortex’s ability to do its most sophisticated work: integrating complex information, managing uncertainty, and making decisions that require holding multiple variables simultaneously. In finance, you can’t outsource that cognitive work. When the sleep deprivation is hormonal in origin, the usual remedies — more coffee, earlier mornings — don’t solve it. Understanding the perimenopause insomnia and anxiety connection is an important starting point for addressing this.
